Terns Pharmaceuticals, Inc. (TERN) has 20 known insider and institutional holders on record. The largest holder is Vivo Capital Surplus Fund VIII, L.P. with 3,581,592 shares. Other notable holders include ORBIMED ADVISORS LLC and GORDON CARL L.
Over the last 12 months, insiders have made 29 transactions in TERN stock — 20 buys (valued at $1.75M) and 8 sells (valued at $1.11M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
TERN Insider Ownership
Top Holder
Vivo Capital Surplus Fund VIII, L.P.
3,581,592 shares
Buys (12 mo)
20
$1.75M value
Sells (12 mo)
8
$1.11M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Vivo Capital Surplus Fund Viii, L.p. |
Director |
3,581,592 |
2022-09-08 |
|
| 2 |
Orbimed Advisors Llc |
10 Percent Owner |
756,258 |
2024-07-17 |
|
| 3 |
Gordon Carl L |
10 Percent Owner |
756,258 |
2024-07-17 |
|
| 4 |
Aden Matthew J |
SVP Worldwide Sales |
500,000 |
2005-08-02 |
|
| 5 |
Lav Biosciences Fund V, L.p. |
Director |
405,583 |
2022-11-28 |
|
| 6 |
Burroughs Amy L. |
Chief Executive Officer |
288,976 |
2026-03-17 |
|
| 7 |
Vivo Opportunity, Llc |
10 Percent Owner |
275,772 |
2024-04-03 |
|
| 8 |
Russell Kerry Strong |
Chief Medical Officer |
240,000 |
2022-07-06 |
|
| 9 |
Chase Jerry D |
Chief Executive Officer |
239,520 |
2004-09-10 |
|
| 10 |
Taylor Arthur T |
SVP, CFO |
125,000 |
2003-05-30 |
|
| 11 |
Kuriakose Emil |
Chief Medical Officer |
105,673 |
2026-04-02 |
|
| 12 |
Gengos Andrew |
Chief Financial Officer |
101,788 |
2026-01-16 |
|
| 13 |
Yoon Seokho Bryan |
COO and General Counsel |
91,940 |
2024-06-04 |
|
| 14 |
Vignola Mark J. |
Chief Financial Officer |
83,811 |
2025-01-06 |
|
| 15 |
Quirk Erin |
President, Head of R&d |
75,000 |
2024-01-25 |
|
| 16 |
Lu Hongbo |
Director |
45,000 |
2025-06-12 |
|
| 17 |
Orbimed Genesis Gp Llc |
Director |
38,450 |
2022-08-18 |
|
| 18 |
Sundaram Senthil Vel |
Chief Executive Officer |
9,770 |
2023-06-02 |
|
| 19 |
Taylor Ann Elizabeth |
Director |
4,676 |
2024-07-02 |
|
| 20 |
Solomon Lewis |
Director |
3,000 |
2005-02-18 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-04-01 |
Kuriakose Emil |
Chief Medical Officer |
Informative Sell |
942 |
$52.75 |
$49.69K |
| 2026-03-16 |
Burroughs Amy L. |
Chief Executive Officer |
Informative Sell |
2,770 |
$47.30 |
$131.03K |
| 2026-02-17 |
Burroughs Amy L. |
Chief Executive Officer |
Informative Sell |
4,083 |
$39.80 |
$162.5K |
| 2026-02-01 |
Quigley Jill M. |
Director |
RSU Award |
1,697 |
$34.60 |
$58.72K |
| 2026-02-01 |
Tripuraneni Radhika |
Director |
RSU Award |
1,697 |
$34.60 |
$58.72K |
| 2026-02-01 |
Azelby Robert |
Director |
RSU Award |
1,697 |
$34.60 |
$58.72K |
| 2026-02-01 |
Turner Heather D |
Director |
RSU Award |
1,697 |
$34.60 |
$58.72K |
| 2026-02-01 |
Kindler Jeffrey B |
Director |
RSU Award |
1,697 |
$34.60 |
$58.72K |
| 2026-02-01 |
Fellows David A |
Director |
RSU Award |
2,828 |
$34.60 |
$97.85K |
| 2026-01-14 |
Kuriakose Emil |
Chief Medical Officer |
RSU Award |
56,250 |
- |
- |
| 2026-01-15 |
Burroughs Amy L. |
Chief Executive Officer |
Informative Sell |
7,521 |
$37.53 |
$282.23K |
| 2026-01-14 |
Burroughs Amy L. |
Chief Executive Officer |
RSU Award |
150,000 |
- |
- |
| 2026-01-14 |
Gengos Andrew |
Chief Financial Officer |
RSU Award |
68,750 |
- |
- |
| 2026-01-02 |
Kuriakose Emil |
Chief Medical Officer |
Informative Sell |
955 |
$38.36 |
$36.63K |
| 2026-01-05 |
Burroughs Amy L. |
Chief Executive Officer |
Option Exercise (Sell) |
150,000 |
- |
- |
| 2026-01-02 |
Burroughs Amy L. |
Chief Executive Officer |
Option Exercise |
21,551 |
$4.64 |
$100K |
| 2025-11-04 |
Quigley Jill M. |
Director |
Informative Sell |
24,520 |
$18.00 |
$441.36K |
| 2025-10-01 |
Kuriakose Emil |
Chief Medical Officer |
Informative Sell |
944 |
$7.85 |
$7.41K |
| 2025-07-01 |
Kuriakose Emil |
Chief Medical Officer |
Informative Sell |
853 |
$4.27 |
$3.64K |
| 2025-06-27 |
Gengos Andrew |
Chief Financial Officer |
Informative Buy |
5,000 |
$3.93 |
$19.63K |
| 2025-06-25 |
Burroughs Amy L. |
Chief Executive Officer |
Informative Buy |
23,314 |
$3.87 |
$90.23K |
| 2025-06-16 |
Gengos Andrew |
Chief Financial Officer |
Informative Buy |
5,000 |
$3.95 |
$19.73K |
| 2025-06-13 |
Gengos Andrew |
Chief Financial Officer |
Informative Buy |
5,000 |
$3.75 |
$18.75K |
| 2025-06-11 |
Quigley Jill M. |
Director |
RSU Award |
45,000 |
$4.10 |
$184.5K |
| 2025-06-11 |
Lu Hongbo |
Director |
RSU Award |
45,000 |
$4.10 |
$184.5K |
